Botulinum Neurotoxin Detection and Differentiation by Mass Spectrometry

John R. Barr, Hércules Moura, Anne E. Boyer, Adrian R. Woolfitt, Suzanne R. Kalb, Antonis J. Pavlopoulos, Lisa G. McWilliams, Jürgen Schmidt, Rodolfo A. Martinez, David L. Ashley

Emerging infectious diseases · 2005 · 186 citations · 12 references

DOIFull text

Open access

Concepts

Abstract

Botulinum neurotoxins (BoNTs) are proteases that cleave specific cellular proteins essential for neurotransmitter release. Seven BoNT serotypes (A-G) exist; 4 usually cause human botulism (A, B, E, and F). We developed a rapid, mass spectrometry-based method (Endopep-MS) to detect and differentiate active BoNTs A, B, E, and F. This method uses the highly specific protease activity of the toxins with target peptides specific for each toxin serotype. The product peptides derived from the endopeptidase activities of BoNTs are detected by matrix-assisted laser-desorption ionization time-of-flight mass spectrometry. In buffer, this method can detect toxin equivalents of as little as 0.01 mouse lethal dose (MLD)50 and concentrations as low as 0.62 MLD50/mL. A high-performance liquid chromatography-tandem mass spectrometry method for quantifying active toxin, where the amount of toxin can be correlated to the amount of product peptides, is also described.

References

12